Query author contributions in Reactome
Reactome depends on collaboration between our curation team and outside experts to
assemble and peer-review its pathway modules. The integration of ORCID within Reactome
enables us to meet a key challenge with authoring, curating and reviewing biological
information by incentivizing and crediting the external experts that contribute their
expertise and time to the Reactome curation process. More information is available at
ORCID and Reactome.
If you have an ORCID ID that is not listed on this page, please
forward this information to us and we will update your Reactome pathway records.
Details on Person Tyrosine agonists reverse the molecular defects associated with dominant-negative mutations in human peroxisome proliferator-activated receptor gamma
| Class:Id | LiteratureReference:9860045 |
|---|
| _displayName | Tyrosine agonists reverse the molecular defects associated with dominant-negative mutations in human peroxisome proliferator-activated receptor gamma |
|---|
| _timestamp | 2024-01-29 21:58:43 |
|---|
| author | [Person:9860050] Agostini, Maura
[Person:9844697] Gurnell, Mark
[Person:9859396] Savage, David B
[Person:9860046] Wood, Emily M
[Person:9858086] Smith, Aaron G
[Person:9860044] Rajanayagam, Odelia
[Person:9860047] Garnes, Keith T
[Person:9860043] Levinson, Sidney H
[Person:5654852] Xu, H Eric
[Person:3772087] Schwabe, John W R
[Person:4717485] Willson, Timothy M
[Person:5603200] O'Rahilly, Stephen
[Person:9860048] Chatterjee, V Krishna |
|---|
| created | [InstanceEdit:9860049] Orlic-Milacic, Marija, 2024-01-29 |
|---|
| journal | Endocrinology |
|---|
| pages | 1527-38 |
|---|
| pubMedIdentifier | 14657011 |
|---|
| title | Tyrosine agonists reverse the molecular defects associated with dominant-negative mutations in human peroxisome proliferator-activated receptor gamma |
|---|
| volume | 145 |
|---|
| year | 2004 |
|---|
| (literatureReference) | [Reaction:9843117] Corepressors are released from liganded PPARG:RXRA heterodimer [Homo sapiens]
[Summation:9860053] Binding of activator ligands to the PPARG:RXRA dimer causes ... |
|---|
|
[Change default viewing format]
|
No pathways have been reviewed or authored by Tyrosine agonists reverse the molecular defects associated with dominant-negative mutations in human peroxisome proliferator-activated receptor gamma (9860045)
